1)
New Tuberculosis Drugs in Development
Author: Laughon, Barbara E. et al
Source: Current Topics in Medicinal Chemistry, Volume 7, Number 5, March 2007 , pp. 463-473(11)
Код: Выделить всё
http://dx.doi.org/10.2174/1568026077800597362)
New Pyrroles with Potential Antimycobacterial, Antifungal and Selective COX-2 Inhibiting Activities. Synthetic Methodologies
Authors: M. Biava,; G. C. Porretta,; G. Poce,; S. Supino,; G. Sleiter,
Source: Current Organic Chemistry, Volume 11, Number 12, August 2007 , pp. 1092-1112(21)
Код: Выделить всё
http://dx.doi.org/10.2174/1385272077813692723)
New Derivatives of BM212: A Class of Antimycobacterial Compounds Based on the Pyrrole Ring as a Scaffold
Authors: Biava, M.1; Porretta, G. C.1; Manetti, F.1
Source: Mini Reviews in Medicinal Chemistry, Volume 7, Number 1, January 2007 , pp. 65-78(14)
Код: Выделить всё
http://dx.doi.org/10.2174/1389557077793177864)
Tuberculosis: Current Treatment and New Drug Development
Authors: Liu, J.1; Ren, H. P.1
Source: Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Volume 5, Number 4, October 2006 , pp. 331-344(14)
DOI пачимута нэту
Код: Выделить всё
http://www.ingentaconnect.com/content/ben/aiamc/2006/00000005/00000004/art00001Mariangela Biava и другие
Bioorganic & Medicinal Chemistry
Volume 13, Issue 4, 15 February 2005, Pages 1221-1230
Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class
Код: Выделить всё
http://dx.doi.org/10.1016/j.bmc.2004.11.018